Leukemia Panel, Custom, (Four Surface Markers)

The leukemia evalution employs cell surface markers to aid in the diagnosis and characterisation of neoplasms of hematopoietic origin. Results are useful in the
differential diagnosis, therapeutic monitoring and detection of relapses of these neoplasms.